Citation Impact
Citing Papers
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection
2016
Co‐morbidity in the ageing haemophilia patient: the down side of increased life expectancy
2009
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Haemostatic materials for wound healing applications
2021 Standout
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors
2005
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
Osteoporosis in haemophilia – an underestimated comorbidity?
2006
Arthrodesis of the ankle and subtalar joints in patients with haemophilic arthropathy
2010
Effect of GB virus C viremia on HIV acquisition and HIV set-point
2005 StandoutNobel
GB virus type C interactions with HIV: the role of envelope glycoproteins
2009
Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis
2020 StandoutNobel
Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis
2006
Long term outcome of patients with acquired haemophilia – A monocentre interim analysis of 82 patients
2013
Synergism between natural products and antibiotics against infectious diseases
2008 Standout
Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5
2004
Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
2015
Application of the “-Omic-” technologies in phytomedicine
2006
Home management of haemophilia
2004
South African GB Virus C Isolates: Interactions between Genotypes 1 and 5 Isolates and HIV
2005
Is There a Relationship between Throbbing Pain and Arterial Pulsations?
2012
GB virus C: the good boy virus?
2012
Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses
2006
Blood coagulation
2000
Extracorporeal Treatment for the Acute und Long-Term Outcome of Patients with Life-Threatening Acquired Hemophilia
2012
Haemophilic arthropathy of the ankle treated by total ankle replacement: a case series
2010
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Haemophilias A and B
2003
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
2007
Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)
2005 StandoutNobel
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C†
2004
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Endemic Venezuelan Equine Encephalitis in the Americas: Hidden Under The Dengue Umbrella
2011
A Synthetic Mimic of Human Fc Receptors: Defined Chemical Modification of Cell Surfaces Enables Efficient Endocytic Uptake of Human Immunoglobulin-G
2006
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
GB Virus Type C: a Beneficial Infection?
2004
Acquired hemophilia A: a review of recent data and new therapeutic options
2017
Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
2008 StandoutNobel
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding
2006 StandoutNobel
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout
Works of L. Heß being referenced
Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C
2003
Long‐term follow‐up after intertrochanteric varus osteotomy for haemophilic arthropathy of the hip
2002
TC‐83 Venezuelan equine encephalitis vaccine exposure during pregnancy
1987
Pain status of patients with severe haemophilic arthropathy
2001
Regulation of CC chemokine receptor 5 in Hepatitis G virus infection
2003
NovoSeven® in immune tolerance therapy
2000
Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
1998
Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept
2004
Reduced CC Chemokine Receptor (CCR) 1 and CCR5 Surface Expression on Peripheral Blood T Lymphocytes from Patients with Chronic Hepatitis C Infection
2002